Antibiotice S.A. (BVB:ATB)

Market Cap	1.63B
Revenue (ttm)	688.90M
Net Income (ttm)	99.42M
Shares Out	671.34M
EPS (ttm)	0.15
PE Ratio	16.41
Forward PE	n/a
Dividend	0.08 (3.41%)
Ex-Dividend Date	Sep 23, 2024

Volume	131,018
Average Volume	121,157
Open	2.420
Previous Close	2.430
Day's Range	2.400 - 2.450
52-Week Range	1.580 - 3.440
Beta	0.10
RSI	41.87
Earnings Date	Feb 25, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company produces medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, ...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,352
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.90 million, an increase of 11.96% compared to the previous year's 615.29 million. Earnings were 99.42 million, an increase of 22.60%.